NorthWest Biotherapeutics Inc (NWBO)

[iclight]

Just being a P3 does not make it pivotal. There are requirements very well likely not met:

" Typically a Phase 3 study which presents the data required by a regulatory agency to decide whether or not to approve a drug. A pivotal study will generally be well-controlled, randomized, of adequate size, and whenever possible, double-blind."

http://www.lillytrials.com/docs/terminology.html#P

Might very well miss on well controlled and adequate size.